Growth Metrics

Oruka Therapeutics (ORKA) Property, Plant & Equipment (Net) (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Oruka Therapeutics 3.04 Bn 2.65 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.42%
Dec 31, 2025 13.83%
Sep 30, 2025 45.40%
Jun 30, 2025 9.43%
Mar 31, 2025 -1.85%
Dec 31, 2024 1.25%
Sep 30, 2024 3,900.00%
Jun 30, 2024 -42.86%
Mar 31, 2024 -30.00%
Dec 31, 2023 -23.08%
Sep 30, 2023 -23.53%
Jun 30, 2023 -19.05%
Mar 31, 2023 -16.00%
Dec 31, 2022 -16.67%
Sep 30, 2022 -18.92%
Jun 30, 2022 -13.95%
Mar 31, 2022 -10.42%
Dec 31, 2021 0.00%
Sep 30, 2021 6.67%
Jun 30, 2021 66.67%
Mar 31, 2021 28.57%
Dec 31, 2020 110.00%
Sep 30, 2020 -16.67%
Jun 30, 2020 20.00%
Mar 31, 2020 0.00%
Dec 31, 2019 0.00%
Sep 30, 2019 -23.08%
Jun 30, 2019 -31.58%
Mar 31, 2019 -20.83%
Dec 31, 2018 -17.24%
Sep 30, 2018 -12.12%
Jun 30, 2018 -10.81%
Mar 31, 2018 -11.90%
Dec 31, 2017 -12.50%
Sep 30, 2017 -11.11%
Jun 30, 2017 -8.47%
Mar 31, 2017 -10.61%
Dec 31, 2016 -4.35%
Sep 30, 2016 -9.21%
Jun 30, 2016 216.67%
Mar 31, 2016 -14.29%
Dec 31, 2015 -9.68%
Sep 30, 2015 -8.82%
Jun 30, 2015 0.00%
Mar 31, 2015 -5.56%
Dec 31, 2014 38.46%
Sep 30, 2014 -10.34%
Jun 30, 2014 11.54%
Mar 31, 2014 -10.34%
Dec 31, 2013 7.41%
Sep 30, 2013 28.57%
Jun 30, 2013 -4.55%
Mar 31, 2013 -4.35%
Dec 31, 2012 -30.30%
Sep 30, 2012 -23.26%
Jun 30, 2012 -17.31%
Mar 31, 2012 -21.21%
Dec 31, 2011 -60.24%
Sep 30, 2011 -66.12%